Libo Pharma Corp. (TPEX:7888)
Taiwan · Delayed Price · Currency is TWD 34.65
-0.85 (-2.39%)
At close: Jun 18, 2026
Libo Pharma Market Cap
Libo Pharma has a market cap or net worth of 2.61 billion as of June 18, 2026.
Market Cap
2.61B
Enterprise Value
1.81B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
34.65
Market Cap Chart
Since December 23, 2025, Libo Pharma's market cap has decreased from 3.55B to 2.61B, a decrease of -26.51%. That is a compound annual growth rate of -47.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.61B | -29.57% |
| Dec 31, 2025 | 3.70B | 4.35% |
| Dec 23, 2025 | 3.55B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmasaga | 13.36B |
| TCM Biotech International | 9.03B |
| Taho Pharmaceuticals | 6.78B |
| Anbogen Therapeutics | 2.21B |
| TEH SENG Pharmaceutical Mfg. | 2.02B |
| Timing Pharmaceutial | 1.74B |
| TSA International | 1.66B |
| Protect Animal Health | 1.62B |